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This paper reports the biochemical characterization of a purified and reconstituted two-component 3-ke-
tosteroid 9-hydroxylase (KSH). KSH of Rhodococcus rhodochrous DSM 43269, consisting of a ferredoxin
reductase (KshB) and a terminal oxygenase (KshA), was heterologously expressed in Escherichia coli. E. coli
cell cultures, expressing both KshA and KshB, converted 4-androstene-3,17-dione (AD) into 9-hydroxy-4-AD
(9OHAD) with a >60% molar yield over 48 h of incubation. Coexpression and copurification were critical to
successfully obtain pure and active KSH. Biochemical analysis revealed that the flavoprotein KshB is an
NADH-dependent reductase using flavin adenine dinucleotide as a cofactor. Reconstitution experiments
confirmed that KshA, KshB, and NADH are essential for KSH activity with steroid substrates. KSH hydroxy-
lation activity was inhibited by several divalent metal ions, especially by zinc. The reconstituted KSH displayed
subtle steroid substrate specificity; a range of 3-ketosteroids, i.e., 5-, 5-, 1, and 4 steroids, could act
as KSH substrates, provided that they had a short side chain. The formation of 9OHAD from AD by KSH was
confirmed by liquid chromatography-mass spectrometry analysis and by the specific enzymatic conversion of
9OHAD into 3-hydroxy-9,10-secoandrost-1,3,5(10)-triene-9,17-dione using 3-ketosteroid 1-dehydrogenase.
Only a single KSH is encoded in the genome of the human pathogen Mycobacterium tuberculosis H37Rv, shown
to be important for survival in macrophages. Since no human KSH homolog exists, the M. tuberculosis enzyme
may provide a novel target for treatment of tuberculosis. Detailed knowledge about the biochemical properties
of KSH thus is highly relevant in the research fields of biotechnology and medicine.
Hydroxylated steroids are pharmaceutically very interesting
bioactive compounds. 9-Hydroxylated steroids are of partic-
ular importance for the synthesis of corticoids such as 9-
fluorohydrocortisone. Microorganisms are widely used for the
stereo-specific hydroxylation of steroids, but little is known
about the enzymes involved, and current processes suffer from
low conversion rates and yields (12, 18, 23).
Rhodococcus species are well known for their broad cata-
bolic potential and ability to degrade sterols and steroids (14,
21, 25, 39). In this paper, we focus on 3-ketosteroid 9-hydrox-
ylase (KSH), which is essential for the growth of Rhodococcus
strains on steroids (38). KSH acts on the B-ring of 3-keto-4
steroids, e.g., 4-androstene-3,17-dione (AD), introducing a 9-
hydroxyl moiety (Fig. 1). Subsequent 1-dehydrogenation of
9-hydroxy-AD (9OHAD) by 3-ketosteroid 1-dehydrogenase
(1-KSTD) initiates the opening of the B-ring through forma-
tion of a chemically unstable intermediate that spontaneous-
ly hydrolyzes, forming 3-hydroxy-9,10-secoandrost-1,3,5(10)-
triene-9,17-dione (3-HSA). KSH activity has been observed in
various actinobacterial genera, e.g., Mycobacterium (1, 3, 6),
Nocardia (35), Arthrobacter (11), and Rhodococcus (38). In
view of their amino acid sequences, KSH enzymes are pre-
dicted to belong to the class IA monooxygenases (5, 38).
Monooxygenases, or mixed-function oxidases, incorporate one
atom of O2 into the substrate (oxygenase function). The sec-
ond atom of O2 is reduced to H2O (oxidase function) (17, 24).
By definition, class IA monooxygenases are two-component
systems consisting of a terminal oxygenase (KshA of KSH) and
a ferredoxin reductase (KshB of KSH). The reductase compo-
nent is a flavoprotein containing an NAD-binding domain and
a plant-type iron-sulfur cluster, [Fe2S2Cys4]. A Rieske-type
iron-sulfur cluster, [Fe2S2Cys2His2], and a non-heme Fe
2-
binding domain are characteristic for the terminal oxygenase
(5, 38). The two protein subunits are linked by an electron
transport chain. NAD(P)H donates electrons to the flavin of
the reductase; these electrons are transferred via the iron-
sulfur clusters to the oxygenase, eventually leading to hydroxy-
lation of the substrate (Fig. 1). The non-heme Fe2 is involved
in the binding and activation of O2 and substrate hydroxylation
(4, 10, 13, 36).
The kshA and kshB genes, encoding KshA and KshB, re-
spectively, were first identified in Rhodococcus erythropolis SQ1
(38). Gene deletion studies have shown that both kshA and
kshB of R. erythropolis SQ1 were required for KSH activity,
suggesting that these two proteins constitute KSH. Biochemi-
cal evidence for this interaction, however, had been lacking. In
fact, knowledge of KSH at the biochemical level has been
extremely limited. Steroid 9-hydroxylation has been reported
to occur in cell extracts of Nocardia restricta (7), and a partly
purified three-component enzyme system of Nocardia species
M117 has been described (35). Heterologous expression of
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kshA of M. smegmatis mc2155 in Escherichia coli has recently
been reported (1, 3). Upon purification, however, KSH activ-
ities were lost or became too low for biochemical character-
ization of the enzyme. Recently, the heterologous expression
and characterization of KSH of Mycobacterium tuberculosis
H37Rv was reported and a crystal structure of KshA was de-
scribed (6). Addition of Fe2-chelating agents to cell cultures
of Rhodococcus rhodochrous DSM 43269 ( IFO3338) incu-
bated with cholesterol was shown to chemically inactivate
KSH, resulting in the accumulation of pharmaceutically inter-
esting steroid pathway intermediates, i.e., 1,4-androstadiene-
3,17-dione (ADD) and 23,24-bisnorcholesta-1,4-diene-22-oic
acid (2). A single kshA ortholog (locus tag rv3526) has been
identified in the genome of the human pathogen M. tubercu-
losis H37Rv (9, 40). Intriguingly, H37Rv genome-wide studies
have revealed that rv3526 is specifically upregulated in macro-
phages and that rv3526 is important for the survival of M.
tuberculosis in macrophages (29, 32, 34). Since no human ho-
molog exists, KSH may provide a novel target for the treatment
of a devastating disease, tuberculosis. Detailed knowledge
about the biochemical properties of KSH thus is highly rele-
vant in the research fields of biotechnology and medicine.
Here, we report the characterization of purified and recon-
stituted KSH and show at the biochemical level that both KshA
and KshB are essential components of the two-component,
iron-sulfur-containing KSH of R. rhodochrous.
MATERIALS AND METHODS
Steroids. Structures of steroids used in this study are shown in Fig. S1 in the
supplemental material. AD, ADD, 19-nor-AD (nordion), 3-hydroxy-5-preg-
nane-20-one, 5-androstan-17-ol-3-one (stanolon), 3-hydroxy-5-androstane-
17-one, and 9-hydroxy-AD were obtained from Schering-Plough. 17-Hydroxy-
4-androstene-3-one (testosterone), 11-hydrocortisone, 4-cholestene-3-one
(cholestenone), and 5-cholestene-3-ol (cholesterol) were obtained from Sigma-
Aldrich. 4-Pregnene-3,20-dione (progesterone) was obtained from ICN
Biomedicals Inc. 1-(5)-Androstene-3,17-dione, 5-androstane-3,17-dione,
5-androstane-3,17-dione, 5-androstane-17-one, and 4-pregnene-3-one-
20-carboxylic acid were obtained from Steraloids.
Cloning of kshA and kshB from R. rhodochrous DSM 43269. Chromosomal
DNA of R. rhodochrous DSM 43269 (DSMZ culture collection, Braunschweig,
Germany) grown in LB (Luria-Bertani) broth (Sigma-Aldrich) was isolated using
a genomic DNA isolation kit (Sigma-Aldrich), digested by Sau3A, sized by
sucrose gradient centrifugation (6 to 10 kb), and ligated into BglII-digested
pRESQ (38). Transformation of E. coli DH5 (Bethesda Research Laborato-
ries) with the ligation mixture generated a genomic library of approximately
16,000 transformants, in which approximately 90% of the constructs contained an
insert. The sizes of the inserts varied considerably (6 to 20 kb).
The kshA gene was identified and isolated from the genomic library of R.
rhodochrous DSM 43269 by PCR using forward primer KshAType-F [5-TG(C/
T)CCITTCCA(C/T)GA(C/T)TGGCGITGGGGIGG] and reverse primer
KshAType-R [5-TGIACGTAAAGAAG(A/G)TGIGCCAT(A/G)TC] (41).
Identification and isolation of kshB were performed with forward primer
KshBcon-F [5-G(G/T/C)CTC(G/C)AACTGG(C/T)TGTGCGA-3] and reverse
primer KshBcon-R [5-TCGCG(A/G)TT(G/C)GCGTAGA(A/C/G/T)CAGC-
3]. PCR was performed in a reaction mixture (25 l) consisting of Tris-HCl (10
mM, pH 8), polymerase buffer, the deoxyribonucleotide triphosphates (0.2 mM),
dimethyl sulfoxide (2%), primers (10 ng/l), and Taq polymerase (0.1 U; Fer-
mentas) under the following conditions: 5 min at 95°C; 30 cycles of 1 min at 95°C,
45 s at 60°C, and 1 min at 72°C; and 5 min at 72°C.
Heterologous kshA and kshB expression and protein purification. The kshA
gene was amplified by PCR (Expand long-template PCR system polymerase [0.1
U/25 l]; Roche) from chromosomal DNA of R. rhodochrous DSM 43269 using
kshA-specific primers (forward primer KshARho-4-F, 5-CATATGACCGTCC
CTCAGGAGCG-3, and reverse primer KshARho-4-R, 5-GCGTCACTCCGC
CGTACCGGCGA-3). The PCR product was cloned into an EcoRV-digested
pZero2.1 (Invitrogen) vector (pKSH804). A 1,176-bp NdeI-BamHI fragment of
pKSH804 was ligated into pET15b (Novagen), which had been digested with
NdeI-BamHI (pKSH808). The kshB gene was amplified by PCR (0.02 U Vent
polymerase; New England Biolabs Inc.) from chromosomal DNA of R. rhodo-
chrous DSM 43269 with kshB-specific primers (forward primer KshBrho-F, 5-
CATATGACGACTGTCGAGGTG-3, and reverse primer KshBrho-R, 5-GG
TTCAGAACTCGATCTTGAGG-3). The PCR product was cloned into
EcoRV-digested pZero2.1 (pBrho4). The 1,119-bp NdeI-HindIII fragment of
pBrho4 was ligated into pET15b, digested with NdeI-HindIII (pBrho5). The
construct for coexpression was made by ligation of a 1,216-bp XbaI-HindIII
fragment of pBrho5 into pKSH808, digested with SpeI-HindIII (pA4rho4) (Fig.
2). Expression plasmids were used to transform E. coli BL21(DE3) (Invitrogen)
or E. coli C41(DE3) (26). Cultures of E. coli harboring expression plasmids were
grown (37°C, 200 rpm) in LB broth supplemented with ampicillin (100 g/ml) to
an optical density at 660 nm (OD660) approximately equal to 0.2. Isopropyl--
D-thiogalactopyranoside (IPTG; 1 mM) was added for induction, and the cul-
tures were incubated at 30°C and 200 rpm for an additional 4 h. The cells were
washed in 50 mM Tris-HCl buffer, pH 7.0, disrupted with a French press, and
centrifuged at 20,000  g for 30 min at 4°C (Sorvall SS-34). All subsequent
purification steps were performed at 4°C. Cell extracts were loaded on a Ni-
nitrilotriacetic acid column (Sigma-Aldrich) for His tag purification and washed
with buffer (50 mM Tris-HCl, pH 7.0, 500 mM NaCl) containing 0, 5, 15, and 30
mM imidazole. KshA and KshB were eluted from the column with 1 to 2 ml of
elution buffer (50 mM Tris-HCl, pH 7.0, 500 mM NaCl, 100 mM imidazole).
Whole-cell steroid bioconversion by recombinant E. coli cells. Cell cultures of
E. coli BL21(DE3) harboring the expression vector pKSH808 (kshA) and cell
cultures of E. coli C41(DE3) harboring the expression vector pBrho5 (kshB) or
pA4rho4 (kshA and kshB) were grown in triplicate in 25 ml LB broth at 37°C to
an OD660 of approximately 0.2. At this point, IPTG (1 mM) and AD (1 g/liter)
were added to the cultures and the incubation was continued at 30°C. Cultures
of E. coli C41(DE3) harboring pET15b were used as a negative control.
Samples were taken 4, 6, 7.5, 24, and 48 h after IPTG induction and diluted
fivefold in 80% methanol-H2O prior to analysis by high-performance liquid
chromatography with UV detection (HPLC-UV) (see below). Product formation
(9OHAD) was quantified using a calibration curve of authentic 9OHAD (200 to
800 M).
Analysis of the KshB flavin cofactor. The flavin cofactor KshB was extracted
in quadruplicate by acid treatment (27). Perchloric acid (70 to 72%) was added
at a 3% (vol/vol) final concentration to purified KshB (0.6 to 1.5 mg/ml protein),
and the mixture was incubated for 1 h at 4°C and centrifuged at 10,000  g for
10 min at 4°C (Sorvall SS-34). The supernatant containing the released flavin was
FIG. 1. Schematic representation of the Rhodococcus two-compo-
nent iron-sulfur monooxygenase KSH comprised of KshA and KshB.
Small arrows indicate electron transfer from NADH to the FAD co-
factor of KshB and via the Fe2S2 clusters to KshA, where substrate
hydroxylation occurs at the Fe2 binding domain. The substrate de-
picted is AD. The product is 9OHAD.
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analyzed by HPLC-UV (375 nm) (reversed-phase C18 column [250 by 4.6 mm],
35°C) using a mobile phase consisting of 20 mM ammonium acetate (pH 6.0) in
9% acetonitrile at a flow rate of 1 ml/min. Under these conditions, the retention
times of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN)
were 6.8 min and 11.2 min, respectively. The flavin cofactor was quantified using
a calibration curve of authentic FAD (7 to 38 M). Measurements were per-
formed in quadruplet with different batches of enzymes.
Noncovalent binding of the flavin cofactor was determined as follows. Purified
KshB (15 g of protein) was run on a sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) gel. The gel was treated with 5% acetic acid solu-
tion and subjected to UV (254 nm) to detect and visualize separated flavin from
KshB.
Standard KshB reductase activity assay. The reductase activity of KshB was
measured spectrophotometrically (600 nm) in an assay with NAD(P)H (0.25
mM) as the electron donor and 2,6-dichlorophenolindophenol (DCPIP; 0.1 mM)
as the electron acceptor (ε  21 mM/cm). KshB (1 to 2 g) was added to the
assay. Assays were performed at room temperature (22°C) in Tris-HCl (50 mM;
pH 7.0) buffer.
Determination of the content of iron and acid-labile sulfur in KshB and KSH.
The iron content of KshB and KSH was determined using the method described
by Fischer and Price (15), as modified by Zabinski et al. (43). FeCl3 was used as
a standard. The acid-labile sulfur contents of these proteins were determined
using the method described by Chen and Mortenson (8).
Standard KSH enzyme activity assay. The KSH activity assay mixture (total
volume, 500 l) consisted of 50 mM Tris-HCl buffer (pH 7.0), NADH (105 M),
and purified, coexpressed KshA and KshB (20 to 25 g). The reaction was
started by the addition of 250 M steroid substrate dissolved in 2-propanol
(100%). All assays were performed at 35°C, unless stated otherwise. Soft-max
PRO4 (Life Science edition) program was used to continuously record NADH
oxidation at 340 nm (ε  6.22 mM/cm). Sigmaplot version 10.0 was used to
process the data using the Michaelis-Menten formula y  (a  x)/(b  x), where
y is the reaction velocity, a is the maximum velocity, x is the substrate concen-
tration, and b is the half-saturation constant. The relation between enzyme
activity and pH was measured using citric acid-phosphate buffers (pHs 5 to 7)
and Tris-HCl buffers (pHs 7 to 9). The low solubility of steroids may affect the
measurement. Therefore, the kinetic parameters do not represent absolute but
rather relative values, providing a strong indication of the substrate preference of
KSH.
Product formation was analyzed by HPLC-UV on an Alltima C18 column (250
by 4.6 mm; particle size, 5 m) at 35°C using methanol-water (80:20) as a mobile
phase (1 ml/min) at 254 nm. Samples were diluted fivefold with 80% methanol in
water prior to analysis.
Confirmation of 9-hydroxy-AD product formation by KSH. A KSH activity
assay was performed using AD as the steroid substrate. The assay mixture
consisted of KSH (184 g/ml), NADH (320 M), AD (200 M), and Tris-HCl
(50 mM, pH 7.0). The mixture was incubated for 16 h at 30°C and 220 rpm.
Steroids were extracted from the assay mixture with dichloromethane and dried
by N2 evaporation.
The extracted steroids (200 M) were analyzed by LC-mass spectrometry
(MS) analysis. HPLC was performed on an Alltima C18 column (250 by 4.6 mm;
particle size, 5 m) at 35°C using methanol-water (80:20) as a mobile phase (0.5
ml/min). MS was performed using atmospheric-pressure chemical ionization.
The extracted steroids were also used as a substrate in an assay with the
1-KSTD enzyme of R. erythropolis SQ1 (20, 37) and analyzed for the formation
of 3-HSA. The 1-KSTD dehydrogenation reaction mixture consisted of KSH
steroid extract (200 M), DCPIP (50 M), and 1-KSTD enzyme (74.8 g/ml)
in Tris-HCl buffer (50 mM pH 7.0). HPLC analysis with diode array detection
was performed using a Lichrosorb reversed-phase C18 column (250 by 4.6 mm)
at 35°C with methanol-water (70:30) as the mobile phase (1 ml/min). Samples
were diluted fivefold in 70% methanol prior to analysis. Authentic 3-HSA (Sche-
ring-Plough, Oss, The Netherlands) was used as a standard.
Influence of metal ions on KSH and KshB activities. Divalent metal ions or
Fe3 ions were added at a final concentration of 100 M to standard KSH or
KshB enzyme assays. Activities measured in a standard assay mixture were set to
100%. No effect on KSH or KshB activity was observed following the addition of
0.1 M HCl (1:100, vol/vol) (the control). The following compounds, prepared in
10 mM stock solutions in 0.1 M HCl, were tested: CaCl2  2H2O, CoSO4  7H2O,
CuCl2  2H2O, FeSO4  7H2O, FeCl3, MgCl2  6H2O, MnSO4  H2O, NiSO4  6H2O,
and ZnSO4  7H2O (4).
Nucleotide sequence accession numbers. DNA nucleotide sequencing was
performed by AGOWA, Berlin, Germany. The sequence data have been sub-
mitted to the DDBJ/EMBL/GenBank databases under accession numbers
FJ238095 (kshA) and FJ238096 (kshB).
RESULTS AND DISCUSSION
Cloning of the kshA and kshB genes from R. rhodochrous
DSM 43269. The kshA gene was identified on a clone from the
genomic library of R. rhodochrous DSM 43269 and isolated by
PCR using primers KshAType-F and KshAType-R. Nucleo-
tide sequencing analysis of the insert (3.2 kb) revealed the
presence of an open reading frame (kshA) of 1,137 nucleotides,
encoding a protein of 378 amino acids with high sequence
similarities to KshA from R. erythropolis SQ1 (58% identity)
and KshA (Rv3526) from Mycobacterium tuberculosis H37Rv
(56% identity). In these three KshA proteins, the Rieske
[Fe2S2Cys2His2] motif (CXHX16CX2H, corresponding to res-
idues 67 to 89 of KshA of R. rhodochrous) and the non-heme
Fe2 motif (DX3DX2Hx4H, residues 174 to 186) were fully
conserved. The kshB gene from R. rhodochrous DSM 43269
was isolated from the genomic library using degenerate prim-
ers (KshBcon-F, KshBcon-R) developed on conserved regions
(SNWLCD, residues 91 to 96, and LXYANRD, residues 151
to 157) identified by alignment of KshB of R. erythropolis SQ1
with orthologous protein sequences found in databases. A
clone carrying kshB (1,056 nucleotides) on a 	15-kb insert was
isolated. R. rhodochrous KshB has 74% amino acid sequence
identity with KshB of R. erythropolis SQ1. The typical class IA
monooxygenase reductase domains previously identified in
KshB of R. erythropolis, a flavin-binding domain (RXYSL, cor-
responding to residues 64 to 69 of KshB of R. rhodochrous), an
NAD-binding domain (GSGITP, residues 128 to 133), and a
C-terminal, plant-type iron-sulfur cluster [Fe2S2Cys4] domain
(CX4CX2CX29C, residues 300 to 338), were fully conserved in
KshB of R. rhodochrous.
Heterologous expression of the KshA and KshB proteins in
E. coli. The kshA and kshB genes were ligated into the pET15b
FIG. 2. Construction of the pA4rho4 vector used for coexpression
of KshA and KshB in E. coli C41(DE3). Both proteins are expressed
with a His tag at their N termini. Abbreviations: amp, ampicillin re-
sistance marker; lacI, lactose repressor gene; RBS, ribosomal binding
site; pT7 (filled squares), T7 promoter for overexpression in E. coli.
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vector for heterologous expression in E. coli. SDS-PAGE anal-
ysis of proteins in cell extracts showed that expression of kshA
(calculated molecular mass of the His-tagged protein, 44.3
kDa) was achieved in E. coli BL21(DE3) but that expression of
kshB (calculated molecular mass of the His-tagged protein,
38.7 kDa) was obtained only with E. coli C41(DE3). Standard
KSH enzyme activity assays, using E. coli extracts with the
KshA and KshB components expressed separately or jointly
plus NADH and AD as substrates, resulted in a clear disap-
pearance of AD and the appearance of a new product, iden-
tified by HPLC-UV as 9OHAD, using an authentic reference
sample (Fig. 3). The time point of IPTG induction for KshA
expression proved crucial for high KSH hydroxylation activity;
specific enzyme activity was considerably higher when IPTG
induction was started at an OD660 of 0.2 instead of an OD660
of 0.5.
Whole-cell steroid bioconversion by recombinant E. coli
cells. Cell cultures of E. coli C41(DE3) coexpressing KshA and
KshB displayed excellent steroid bioconversion potential, con-
verting AD (1 g/liter) into 9OHAD within 48 h of incubation
after IPTG induction in a 
60% molar yield (Fig. 4). No AD
conversion occurred with E. coli cells expressing only KshA or
KshB, indicating that both KshA and KshB are essential com-
ponents of KSH activity. Conversion of AD to 9OHAD was
also not detected in cultures of E. coli C41(DE3) harboring the
pET15b vector as a negative control.
(Co)Purification of KshA and KshB proteins. Both KSH
subunits KshA and KshB were His tag purified separately.
Addition of the purified KSH subunits separately to a standard
KSH assay mixture with AD as a substrate, however, did not
result in detectable KSH activity. Purified KshB was still active
in the reductase assay with DCPIP, indicating either that the
KshA component lost activity upon purification or that recon-
stitution of a functional KshAB enzyme complex failed. The
purified R. rhodochrous KshB (0.5 to 2 mg/ml protein) could be
stored (in 20% glycerol) at 20°C for several weeks without
significant loss of activity. In contrast, rapid loss of KSH activ-
ity was observed in cell extracts stored at 20°C (in 20%
glycerol). These observations indicate that the R. rhodochrous
KshA protein was unstable under these conditions.
Interestingly, active KshA could be purified when E. coli
extract with KshA was mixed with E. coli extract with KshB,
prior to the loading of these extracts onto the Ni-nitrilotriace-
tic acid column. This resulted in coelution of both proteins and
detection of KSH activity in the standard assay. As an alter-
native, plasmid pA4rho4 (Fig. 2) was constructed to attempt
coexpression of kshA and kshB in E. coli C41(DE3) and sub-
sequent copurification of KshA and KshB proteins (Fig. 5).
Coexpression and copurification of KshA and KshB dramati-
cally enhanced the in vitro KSH enzyme activity. This marked
effect of coexpression and copurification on KSH activity
strongly suggests that protein-protein interactions between the
KshA and KshB subunits are critically important for maintain-
ing KSH activity. KshA may be kept in a reduced state by the
presence of KshB during purification, mimicking purification
in the presence of reducing agents or under anaerobic condi-
tions, as has been reported for several other related oxygenases
(4, 6, 22, 30, 42). The molar ratio of KshA and KshB protein in
purified KSH was determined as 1:(0.83	 0.058). The iron and
acid-labile sulfur content of KSH was determined to be 3.94 	
FIG. 3. HPLC elution profiles confirming the AD 9-hydroxylation
activity of E. coli-expressed KshA and KshB components. Profile a,
Authentic reference sample of 9OHAD; profile b, authentic reference
sample of AD; profile c, product analysis following incubation of
KshA, KshB, NADH (140 M), and AD (200 M) in Tris-HCl buffer
(50 mM, pH 7.0).
FIG. 4. Bioconversion of AD into 9-OHAD by E. coli C41(DE3)
cell cultures coexpressing KshA and KshB. E. coli BL21(DE3) cells
expressing KshA alone and E. coli C41(DE3) cells harboring pET15b
showed no conversion of AD into 9OHAD at 48 h after IPTG induc-
tion. Error bars indicate standard errors of the means (from three
experiments). Time points are numbers of hours after IPTG induction.
Filled circles indicate increases in the biomass of E. coli C41(DE3)
coexpressing KshA and KshB, measured as turbidity of the cell culture
at the OD660.
FIG. 5. Lanes: a, SDS-PAGE analysis of protein markers; b, E. coli
cell extract coexpressing KshA and KshB; c, E. coli cell extract express-
ing KshB; d, His tag-copurified KshA (45.4 kDa)/KshB (40 kDa) (10
g); e, His tag-purified KshB (10 g).
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0.08 mol and 4.3 	 1 mol per mol of KSH, respectively. The
spectra of purified and dithionite-reduced KSH were charac-
teristic for the presence of an [Fe2S2] cluster (Fig. 6A). The
activity of purified KSH could now be determined spectropho-
tometrically by measuring substrate (e.g., AD)-dependent
NADH oxidation at 340 nm, which was not possible in cell
extracts because of high background NADH oxidation activity.
Dialysis of the purified sample (3 h at 4°C) to remove imid-
azole and NaCl reduced KSH activity to about 30% of the
original activity, which could have resulted from the loss of
non-heme Fe2 present in KshA during dialysis. However, the
loss of activity could not be restored by the addition of Fe2
and thus might have resulted from protein unfolding or loss of
protein-protein interactions between KshA and KshB follow-
ing dialysis. Undialyzed, purified KSH (1 to 2 mg/ml) could be
stored for at least 2 weeks in 20% glycerol at 20°C without
significant loss of activity and was used for all subsequent
experiments.
Biochemical characterization of KshB as an NADH-depen-
dent oxygenase-reductase. In the reductase assay with DCPIP,
purified KshB was strictly NADH dependent for activity (spe-
cific activity 4.1 mol min1 mg1). No activity was found in
a reductase assay with NADPH as the electron donor. Purified
KshB had an orange color, which is in agreement with the
presence of a flavin and a plant-type iron-sulfur cluster (4).
Cofactor extraction from KshB and subsequent HPLC analysis
of this extract identified the cofactor as FAD (0.72 	 0.14 mol
FAD per mol KshB) (Fig. 7). The spectrum of KshB was
consistent with the presence of an [Fe2S2] cluster (Fig. 6B).
The purified material contained 1.75 	 0.25 mol iron and
2.03 	 0.37 mol acid-labile sulfur per mol of KshB. The flavin
cofactor of KshB is clearly noncovalently bound, running sep-
arately from KshB on an SDS-PAGE gel, visualized by acetic
acid treatment of an SDS-PAGE gel and UV (254 nm) irradi-
ation.
The amino acid sequences of KshA and KshB predict that
Rhodococcus KSH belongs to the class IA monooxygenases
(38; this study). By definition, oxygenase reductases of class IA
monooxygenases contain FMN as a cofactor, whereas class IB
oxygenase reductases contain FAD (5). Our finding in the
present study that FAD acts as a KshB cofactor thus is not
consistent with the classification of this protein in class IA.
Several other examples of enzymes that do not fit the Batie
classification of ring-hydroxylating oxygenases have been re-
ported (19, 31, 33). Another classification system has been
proposed for oxygenase components involved in ring-hydroxy-
lating oxygenations (28). In this scheme, based on amino acid
sequences of terminal oxygenases, KshA of KSH belongs to
FIG. 6. Absorption spectra of KSH (57.5 M) (A) and KshB (33 M) (B) as purified (thin line) and after dithionite (10 mM) treatment (thick
line).
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group I. Enzymes of group I vary greatly, however, in the
amino acid sequence of the oxygenase component, contain
either two or three components, and include both monooxy-
genases and dioxygenases. Further biochemical characteristics
thus appear required for proper classification of oxygenases.
Characteristics of the reconstituted KSH enzyme system. To
confirm that KSH activity is dependent on KshA, KshB, and
NADH, we performed standard steroid hydroxylation activity
assays using AD as the substrate and analyzed product forma-
tion by HPLC. Purified KshB and E. coli cell extracts contain-
ing active KshA were used, instead of copurified KshA and
KshB, enabling us to omit each of the components of the KSH
system. Omitting KshA, KshB, or NADH separately from the
reaction mixture resulted in no detectable KSH activity, indi-
cating that these are all essential components. Interestingly,
the KSH-specific activity of copurified KshA and KshB (16
g), using AD (100 M) as the substrate, could be maximally
enhanced nearly twofold by the addition of purified KshB (15
g) (510 	 8 nmol min1 mg1 KSH). At saturated KshB
levels (4 g copurified KshAB with 34 g KshB), however, the
KSH-specific activity was significantly lower (150 	 18 nmol
min1 mg1 KSH). Since the increase in KSH-specific activity
was less than twofold, we decided to perform all subsequent
experiments with copurified KSH without the addition of pu-
rified KshB.
Next, the optimal temperature and pH of KSH were deter-
mined using copurified KshA/KshB. Activity measurements at
different temperatures and pH values revealed a rather narrow
pH range with an optimum of pH 7.0 and a temperature
optimum of 33°C. No decrease in the initial KSH enzyme
activity was observed after a 5-min preincubation at 35°C,
indicating that the KSH enzyme was stable during the assay.
Initial activity was reduced by 25% following a 30-min prein-
cubation at 35°C.
The KSH-dependent introduction of a 9-hydroxyl moiety
into AD was also investigated. The hydroxylated product
formed during an overnight incubation of AD (200 M) with
copurified and reconstituted KSH was extracted and analyzed
by LC-MS. The MS spectrum of the product of the KSH
activity assay was identical to the spectrum of authentic
9OHAD, confirming C9-hydroxylation by KSH.
The steroid extract from the KSH reaction mixture was
additionally used in a 1-KSTD enzyme assay. 1-Dehydro-
genation of 9OHAD results in a chemically unstable com-
pound (9OHADD), leading to a nonenzymatic B-ring opening
and the formation of 3-HSA. HPLC analysis with diode array
detection of the KSTD reaction mixture indeed confirmed the
disappearance of 9OHAD and the formation of 3-HSA.
The non-heme Fe2 binding domain of KshA is predicted to
be important in catalysis (10). Indeed, addition of o-phenan-
throline (100 M), a highly specific Fe2 chelator, to the stan-
dard KSH enzyme assay resulted in an 80% reduction of KSH
activity. The activity of KshB in the reductase assay was not
reduced by the same treatment, confirming that Fe2 bound in
the non-heme Fe2 domain in KshA is important for KSH
activity.
Influence of divalent metal ions on KshB reductase and
KSH activities. The influence of metal ions on KshB reductase
and KSH activities in a standard enzyme assay was studied
(Table 1). AD (100 M) was added as the substrate to the
KSH activity assay. None of the metal ions added enhanced the
activity of KSH or KshB substantially. Addition of Fe2, Ca2,
Mn2, or Mg2 to the enzyme mixture had a significant effect
neither on KSH activity nor on KshB reductase activity. Sev-
eral metals, however, were shown to inhibit the hydroxylation
activity. Zn2 was the strongest inhibitor, completely abolish-
ing KSH activity. The inhibitory effects of Fe3, Co2, Zn2,
and Ni2 on KSH activity clearly are KshA specific, since the
reductase activity of KshB was not inhibited by these metal
ions. KshB was inhibited only by copper. It has been reported
that copper can disrupt the binding of FAD (16). In view of the
inhibitory effect of Ni2 on KSH activity, the nickel affinity
column chromatography step used for purification of His-
tagged proteins in hindsight appears less suited. This may at
least partly explain the KshA activity loss.
KSH acts on 3-ketosteroids with a range of A-ring configu-
rations. To determine the substrate range of KSH, standard
enzyme assays were performed with a range of steroid sub-
FIG. 7. HPLC elution profiles identifying FAD as the flavin cofactor of KshB. Profile a, flavin cofactor extracted from KshB by acid treatment;
profile b, authentic FAD; profile c, authentic FMN.
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strate concentrations (10 to 250 M) with copurified KshA/
KshB, and NADH oxidation was measured at 340 nm. No
NADH oxidation was observed in a KSH standard enzyme
assay without the addition of steroid substrate. Steroid sub-
strates were tested with variations in A-ring configuration and
side chain length (Table 2). The enzyme followed Michaelis-
Menten kinetics, and maximal reaction rates were observed
with several substrates in the range of 10 to 100 M. NADH
oxidation was well coupled to steroid substrate utilization as
determined by HPLC or gas chromatography. The highest
KSH activity was observed with AD, ADD, 4-androstene-17-
ol-3-one (testosterone) and 4-pregnene-3,20-dione (progester-
one) (Table 2). Km values for these substrates, however, were
below 10 M and could not be determined accurately, since
KSH reaction rates at substrate concentrations below 10 M
resulted in minimal differences in absorbance at 340 nm and
inaccurate Michaelis-Menten curves. On the other hand, Km
values for 19-nor-AD (10 	 1 M), 5-androstane-3,17-dione
(23 	 2 M), and 5-androstane-3,17-dione (33 	 5 M)
could be accurately determined.
KSH accepts a variety of steroid substrates with different
A-ring confirmations. The highest KSH activity was observed
with 3-keto-4 steroid substrates, e.g., AD. The presence of a
3-keto moiety appears essential for KSH activity: no activity
was found with 3- or 3-hydroxysteroids or steroids without a
hydroxyl moiety at this position. The configuration of the A-
ring does not appear to play an important role in determining
substrate specificity, provided that a 3-keto moiety is present.
Activity was observed with saturated 3-ketosteroids having ei-
ther a 5-H or a 5-H configuration, as well as with unsatur-
ated 1, 4, and 1,4 3-ketosteroids (Table 2). Striking is the
difference in substrate affinity observed for 1-(5)-androstene-
3,17-dione and 5-androstane-3,17-dione. The 1 unsaturated
bond in the former appears to make the substrate more favor-
able for the enzyme, suggesting that in vivo 9-hydroxylation
might be preceded by 1-dehydrogenation. The ability of KSH
to use 4-androstene-17-ol-3-one (testosterone) but not 5-
androstane-17-ol-3-one (stanolon) as a substrate is remark-
able, since activity was observed with 5-androstane-3,17-di-
one. Apparently, the active site of KshA cannot accommodate
steroids with a 17-hydroxyl group and a 5-H-configuration
simultaneously. The substituent present at the C-17 position of
the steroid molecule appears to be an important determinant
of KSH substrate specificity. Unlike with progesterone, a C21
steroid with a relatively small side chain, no KSH activity
was observed with 4-pregnene-3-one-20-carboxylic acid
(C22) or 4-cholestene-3-one (C27), with more bulky side
chains (Table 2).
The stereo-specific steroid hydroxylation catalyzed by the
KSH system, its subtle substrate specificity for various 3-keto-
steroids, and the efficient use of AD in E. coli whole-cell
bioconversions make this R. rhodochrous DSM 43269 enzyme
an interesting candidate for industrial applications.
ACKNOWLEDGMENTS
This project is financially supported by The Netherlands Ministry of
Economic Affairs and B-Basic partner organizations (http://www.b-basic
.nl) through B-Basic, a public/private NWO (Netherlands Organization
for Scientific Research)-ACTS (Advanced Chemical Technologies for
Sustainability) program. Schering-Plough (Oss, The Netherlands) also
supported this project.
We gratefully acknowledge Jan Knol (University of Groningen) for
supplying 1-KSTD enzyme and the Department of Biochemistry
(University of Groningen) for use of equipment and assistance with
LC-MS.
REFERENCES
1. Andor, A., A. Jekkel, D. A. Hopwood, F. Jeanplong, E. Ilkoy, A. Konya, I.
Kurucz, and G. Ambrus. 2006. Generation of useful insertionally blocked
sterol degradation pathway mutants of fast-growing mycobacteria and clon-
ing, characterization, and expression of the terminal oxygenase of the 3-ke-
tosteroid 9-hydroxylase in Mycobacterium smegmatis mc2155. Appl. Envi-
ron. Microbiol. 72:6554–6559.
2. Arima, K., W. Nakamatsu, and T. Beppu. 1978. Microbial production of
3-oxobisnorchola-1,4-dien-22-oic acid. Agric. Biol. Chem. 42:411–416.
3. Arnell, R., R. Johannisson, J. Lindholm, T. Fornstedt, B. Ersson, A. Ballagi,
and K. Caldwell. 2007. Biotechnological approach to the synthesis of 9alpha-
hydroxylated steroids. Prep. Biochem. Biotechnol. 37:309–321.
4. Batie, C. J., E. LaHaie, and D. P. Ballou. 1987. Purification and character-
ization of phthalate oxygenase and phthalate oxygenase reductase from
Pseudomonas cepacia. J. Biol. Chem. 262:1510–1518.
5. Batie, C. J., D. P. Ballou, and C. J. Correll. 1991. Phthalate dioxygenase
reductase and related flavin-iron-sulfur containing electron transferases, p.
543–556. In F. Mu¨ller (ed.), Chemistry and biochemistry of flavoenzymes.
CRC Press, Boca Raton, FL.
TABLE 1. Effect of metal ions on the activities of KshB and KSH,
displayed as percentages of control activities
Assay
Activity with indicated metal ion relative to control activity (%)a
None Fe2 Fe3 Cu2 Ca2 Co2 Zn2 Mn2 Mg2 Ni2
KshB 100 —b 111 8 116 102 80 98 103 78
KSH 100 98 40 18 95 36 0 103 91 23
a Control activity is the activity measured in a standard assay, which was set at
100%.
b The influence of Fe2 on the KshB reductase activity could not be deter-
mined because of interference with the assay.
TABLE 2. Steroid substrate range of the KSH enzyme of
R. rhodochrous DSM 43269a




AD 276 	 20 100
ADD 246 	 20 89
4-Androstene-17-ol-3-one (testosterone) 279 	 29 101
4-Pregnene-3,20-dione (progesterone) 272 	 38 99
19-Nor-4-androstene-3,17-dione (nordion) 216 	 25 78
1-(5)-Androstene-3,17-dione 188 	 20 68
5-Androstane-3,17-dioneb 177 	 19 64
5-Androstane-3,17-dioneb 160 	 22 58
5-Cholestene-3-ol (cholesterol)c ND ND






4-Pregnene-3-one-20-carboxylic acidc ND ND
9OHAD (negative control) ND ND
a Experimental enzyme activities (Exptl Vmax) at a 100 M steroid substrate
concentration were calculated in nmol1  min1  mg1 KSH enzyme. The rel-
ative activities are expressed as percentages of the activity with AD, which was set
at 100%. Errors were calculated as standard errors of the means (from three
experiments). Steroid structures are shown in Fig. S1 in the supplemental ma-
terial. ND, no detectable activity.
b Steroid substrate concentration, 200 M.
c Steroid substrate concentration, 25 M, due to the low solubility of the
substrate.
5306 PETRUSMA ET AL. APPL. ENVIRON. MICROBIOL.
6. Capyk, J. K., I. D’Angelo, N. C. Strynadka, and L. D. Eltis. 2009. Charac-
terization of 3 ketosteroid 9-hydroxylase, a Rieske oxygenase in the cho-
lesterol degradation pathway of Mycobacterium tuberculosis. J. Biol. Chem.
284:9937–9946.
7. Chang, F. N., and C. J. Sih. 1964. Mechanisms of steroid oxidation by
microorganisms. VII. Properties of the 9-hydroxylase. Biochemistry
3:1551–1557.
8. Chen, J.-S., and L. E. Mortenson. 1977. Inhibition of methylene blue for-
mation during determination of the acid-labile sulfide of iron-sulfur protein
samples containing dithionite. Anal. Biochem. 79:157–165.
9. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V.
Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D.
Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T.
Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh,
J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. A. Quail, M. A.
Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S.
Squares, J. E. Sulston, K. Taylor, S. Whitehead, and B. G. Barrell. 1998.
Deciphering the biology of Mycobacterium tuberculosis from the complete
genome sequence. Nature 393:537–544.
10. Coulter, E. D., N. Moon, C. J. Batie, W. R. Dunham, and D. P. Ballou. 1999.
Electron paramagnetic resonance measurements of the ferrous mononuclear
site of phthalate dioxygenase substituted with alternate metal ions: direct
evidence for ligation of two histidines in the copper(II)-reconstituted pro-
tein. Biochemistry 38:11062–11072.
11. Dutta, R. K., M. K. Roy, and H. D. Singh. 1992. Role of plasmid pJL1 of
Arthrobacter oxydans 317 in the degradation of -sitosterol. J. Basic Micro-
biol. 32:317–324.
12. Fernandes, P., A. Cruz, B. Angelova, H. M. Pinheiro, and J. M. S. Cabral.
2003. Microbial conversion of steroid compounds: recent developments.
Enzyme Microb. Technol. 32:688–705.
13. Ferraro, D. J., L. Gakhar, and S. Ramaswamy. 2005. Rieske business: struc-
ture-function of Rieske non-heme oxygenases. Biochem. Biophys. Res. Com-
mun. 338:175–190.
14. Finnerty, W. R. 1992. The biology and genetics of the genus Rhodococcus.
Annu. Rev. Microbiol. 46:193–218.
15. Fischer, D. S., and D. C. Price. 1964. A simple serum iron method using the
new sensitive chromogen tripyridyl-s-triazine. Clin. Chem. 10:21–31.
16. Green, J., S. D. Prior, and H. Dalton. 1985. Copper ions as inhibitors of
protein C of soluble methane monooxygenase of Methylococcus capsulatus
(Bath). Eur. J. Biochem. 153:137–144.
17. Harayama, S., M. Kok, and E. L. Neidle. 1992. Functional and evolutionary
relationships among diverse oxygenases. Annu. Rev. Microbiol. 46:565–601.
18. Holland, H. L. 1999. Recent advances in applied and mechanistic aspects of
the enzymatic hydroxylation of steroids by whole-cell biocatalysts. Steroids
64:178–186.
19. Jouanneau, Y., C. Meyer, J. Jakoncic, V. Stojanoff, and J. Gaillard. 2006.
Characterization of a ring-hydroxylating dioxygenase able to oxidize a wide
range of polycyclic aromatic hydrocarbons including four and five ring car-
cinogens. Biochemistry 45:12380–12391.
20. Knol, J., K. Bodewits, G. I. Hessels, L. Dijkhuizen, and R. van der Geize.
2008. 3-Keto-5alpha-steroid delta(1)-dehydrogenase from Rhodococcus
erythropolis SQ1 and its orthologue in Mycobacterium tuberculosis H37Rv are
highly specific enzymes that function in cholesterol catabolism. Biochem. J.
410:339–346.
21. Larkin, M. J., L. A. Kulakov, and C. C. Allen. 2005. Biodegradation and
Rhodococcus—masters of catabolic versatility. Curr. Opin. Biotechnol. 16:
282–290.
22. Locher, H. H., T. Leisinger, and A. M. Cook. 1991. 4-Sulphobenzoate 3,4-
dioxygenase: purification and properties of a desulphonative two-component
enzyme system from Comamonas testosterone T-2. Biochem. J. 274:833–842.
23. Mahato, S. B., and S. Garai. 1997. Advances in microbial steroid biotrans-
formation. Steroids 62:332–345.
24. Mason, J. R., and R. Cammack. 1992. The electron transport proteins of
hydroxylating bacterial dioxygenases. Annu. Rev. Microbiol. 46:277–305.
25. McLeod, M. P., R. L. Warren, W. W. Hsiao, N. Araki, M. Myhre, C. Fer-
nandes, D. Miyazawa, W. Wong, A. L. Lillquist, D. Wang, M. Dosanjh, H.
Hara, A. Petrescu, R. D. Morin, G. Yang, J. M. Stott, J. E. Schein, H. Shin,
D. Smailus, A. S. Siddiqui, M. A. Marra, S. J. Jones, R. Holt, F. S. Brinkman,
K. Miyauchi, M. Fukuda, J. E. Davies, W. W. Mohn, and L. D. Eltis. 2006.
The complete genome of Rhodococcus sp. RHA1 provides insights into a
catabolic powerhouse. Proc. Natl. Acad. Sci. USA 103:15582–15587.
26. Miroux, B., and J. E. Walker. 1996. Over-production of proteins in Esche-
richia coli: mutant hosts that allow synthesis of some membrane proteins and
globular proteins at high levels. J. Mol. Biol. 260:289–298.
27. Mohamed, M. E.-S., A. Zaar, C. Ebenau-Jehle, and G. Fuchs. 2001. Rein-
vestigation of a new type of aerobic benzoate metabolism in the proteobac-
terium Azoarcus evansii. J. Bacteriol. 183:1899–1908.
28. Nam, J. W., H. Nojiri, T. Yoshida, H. Habe, H. Yamane, and T. Omori. 2001.
New classification system for oxygenase components involved in ring-hy-
droxylating oxygenations. Biosci. Biotechnol. Biochem. 65:254–263.
29. Rengarajan, J., B. R. Bloom, and E. J. Rubin. 2005. Genome-wide require-
ments for Mycobacterium tuberculosis adaptation and survival in macro-
phages. Proc. Natl. Acad. Sci. USA 102:8327–8332.
30. Rosche, B., B. Tsisuaka, S. Fetzner, and F. Lingens. 1995. 2-Oxo-1,2-dihy-
droquinoline 8-monooxygenase, a two-component enzyme system from
Pseudomonas putida 86. J. Biol. Chem. 270:17836–17842.
31. Rosche, B., B. Tshisuaka, B. Hauer, F. Lingens, and S. Fetzner. 1997.
2-Oxo-1,2-dihydroquinoline 8-monooxygenase: phylogenetic relationship to
other multicomponent nonheme iron oxygenases. J. Bacteriol. 179:3549–
3554.
32. Sassetti, C. M., and E. J. Rubin. 2003. Genetic requirements for mycobac-
terial survival during infection. Proc. Natl. Acad. Sci. USA 100:12989–12994.
33. Sato, S., J. W. Nam, K. Kasuga, H. Nojiri, H. Yamane, and T. Omori. 1997.
Identification and characterization of genes encoding carbazole 1,9-dioxy-
genase in Pseudomonas sp. strain CA10. J. Bacteriol. 179:4850–4858.
34. Schnappinger, D., S. Ehrt, M. I. Voskuil, Y. Liu, J. A. Mangan, I. M.
Monahan, G. Dolganov, B. Efron, P. D. Butcher, C. Nathan, and G. K.
Schoolnik. 2003. Transcriptional adaptation of Mycobacterium tuberculosis
within macrophages: insights into the phagosomal environment. J. Exp. Med.
198:693–704.
35. Strijewski, A. 1982. The steroid-9 alpha-hydroxylation system from Nocardia
species. Eur. J. Biochem. 128:125–135.
36. Tarasev, M., and D. P. Ballou. 2005. Chemistry of the catalytic conversion of
phthalate into its cis-dihydrodiol during the reaction of oxygen with the
reduced form of phthalate dioxygenase. Biochemistry 44:6197–6207.
37. van der Geize, R., G. I. Hessels, R. van Gerwen, P. van der Meijden, and L.
Dijkhuizen. 2001. Unmarked gene deletion mutagenesis of kstD, encoding
3-ketosteroid delta1-dehydrogenase, in Rhodococcus erythropolis SQ1 using
sacB as counter-selectable marker. FEMS Microbiol. Lett. 205:197–202.
38. van der Geize, R., G. I. Hessels, R. Van Gerwen, P. Van der Meijden, and L.
Dijkhuizen. 2002. Molecular and functional characterization of kshA and
kshB, encoding two components of 3-ketosteroid 9-hydroxylase, a class IA
monooxygenase, in Rhodococcus erythropolis strain SQ1. Mol. Microbiol.
45:1007–1018.
39. van der Geize, R., and L. Dijkhuizen. 2004. Harnessing the catabolic diversity
of rhodococci for environmental and biotechnological applications. Curr.
Opin. Microbiol. 7:255–261.
40. Van der Geize, R., K. Yam, T. Heuser, M. H. Wilbrink, H. Hara, M. C.
Anderton, E. Sim, L. Dijkhuizen, J. E. Davies, W. W. Mohn, and L. D. Eltis.
2007. A gene cluster encoding cholesterol catabolism in a soil actinomycete
provides insight into Mycobacterium tuberculosis survival in macrophages.
Proc. Natl. Acad. Sci. USA 104:1947–1952.
41. van der Geize, R., G. I. Hessels, M. Nienhuis-Kuiper, and L. Dijkhuizen.
2008. Characterization of a second 3-ketosteroid 9-hydroxylase activity in
Rhodococcus erythropolis SQ1 comprised of a terminal oxygenase homo-
logue, KshA2, active with oxygenase-reductase component KshB. Appl. En-
viron. Microbiol. 74:7197–7203.
42. Wolfe, M. D., D. J. Altier, A. Stubna, C. V. Popescu, E. Mu¨nck, and J. D.
Lipscomb. 2002. Benzoate 1,2-dioxygenase from Pseudomonas putida: single
turnover kinetics and regulation of a two-component Rieske dioxygenase.
Biochemistry 41:9611–9626.
43. Zabinski, R., E. Mu¨nck, P. M. Champion, and J. M. Wood. 1972. Kinetic and
Mo¨ssbauer studies on the mechanism of protocatechuic acid 4,5-oxygenase.
Biochemistry 11:3212–3219.
VOL. 75, 2009 CHARACTERIZATION OF 3-KETOSTEROID 9-HYDROXYLASE 5307
